Tremor is a prominent phenotype of the twitcher mouse, an authentic genetic model of Globoid-Cell Leukodystrophy (GLD, Krabbe’s disease). In the current study, the tremor was quantified using a force-plate actometer designed to accommodate low-weight mice. The actometer records the force oscillations caused by a mouse’s movements, and the rhythmic structure of the force variations can be revealed. Results showed that twitcher mice had significantly increased power across a broad band of higher frequencies compared to wildtype mice. Bone marrow transplantation (BMT), the only available therapy for GLD, worsened the tremor in the twitcher mice and induced a measureable alteration of movement phenotype in the wildtype mice. These data highlight the damaging effects of conditioning radiation and BMT in the neonatal period. The behavioral methodology used herein provides a quantitative approach for assessing the efficacy of potential therapeutic interventions for Krabbe’s disease.
References
[1]
Suzuki, K.; Suzuki, Y.; Suzuki, K.; Wenger, D.A. Galactosylceramide Lipidosis: Globoid Cell Leukodystrophy (Krabbe Disease). In Metabolic and Molecular Bases of Inherited Diseases; McGraw-Hill Professional: New York, NY, USA, 2000.
[2]
Suzuki, K.; Suzuki, K. The twitcher mouse: A model for Krabbe disease and for experimental therapies. Brain Pathol. 1995, 5, 249–258, doi:10.1111/j.1750-3639.1995.tb00601.x.
[3]
Suzuki, K.; Suzuki, K. The twitcher mouse. A model of human globoid cell leukodystrophy (krabbe’s disease). Am. J. Pathol. 1983, 111, 394–397. 6859223
[4]
Hofling, A.A.; Kim, J.H.; Fantz, C.R.; Sands, M.S.; Song, S.-K. Diffusion tensor imaging detects axonal injury and demyelination in the spinal cord and cranial nerves of a murine model of globoid cell leukodystrophy. NMR Biomed. 2009, 22, 1100–1106. 19650072
[5]
Castelvetri, L.C.; Givogri, M.I.; Zhu, H.; Smith, B.; Lopez-Rosas, A.; Qiu, X.; van Breemen, R.; Bongarzone, E.R. Axonopathy is a compounding factor in the pathogenesis of Krabbe disease. Acta Neuropathol. 2011, 122, 35–48, doi:10.1007/s00401-011-0814-2.
[6]
Fowler, S.C.; Birkestrand, B.R.; Chen, R.; Moss, S.J.; Vorontsova, E.; Wang, G.; Zarcone, T.J. A force-plate actometer for quantitating rodent behaviors: Illustrative data on locomotion, rotation, spatial patterning, stereotypies, and tremor. J. Neurosci. Methods 2001, 107, 107–124, doi:10.1016/S0165-0270(01)00359-4. 11389948
[7]
Sakai, N.; Inui, K.; Tatsumi, N.; Fukushima, H.; Nishigaki, T.; Taniike, M.; Nishimoto, J.; Tsukamoto, H.; Yanagihara, I.; Ozono, K.; et al. Molecular cloning and expression of cDNA for murine galactocerebrosidase and mutation analysis of the twitcher mouse, a model of Krabbe’s disease. J. Neurochem. 1996, 66, 1118–1124. 8769874
[8]
Okabe, M.; Ikawa, M.; Kominami, K.; Nakanishi, T.; Nishimune, Y. ‘Green mice’ as a source of ubiquitous green cells. FEBS Lett. 1997, 407, 313–319, doi:10.1016/S0014-5793(97)00313-X.
Wang, G.; Fowler, S. Concurrent quantification of tremor and depression of locomotor activity induced in rats by harmaline and physostigmine. Psychopharmacology 2001, 158, 273–280, doi:10.1007/s002130100882.
[11]
McMahon, A.; Fowler, S.C.; Perney, T.M.; Akemann, W.; Kn？pfel, T.; Joho, R.H. Allele-dependent changes of olivocerebellar circuit properties in the absence of the voltage-gated potassium channels Kv3.1 and Kv3.3. Eur. J. Neurosci. 2004, 19, 3317–3327, doi:10.1111/j.0953-816X.2004.03385.x. 15217387
[12]
Lin, D.; Donsante, A.; Macauley, S.; Levy, B.; Vogler, C.; Sands, M.S. Central nervous system-directed AAV2/5-mediated gene therapy synergizes with bone marrow transplantation in the murine model of globoid-cell leukodystrophy. Mol. Ther. 2007, 15, 44–52, doi:10.1038/sj.mt.6300026.
[13]
Reddy, A.S.; Kim, J.H.; Hawkins-Salsbury, J.A.; Macauley-Rambach, S.L.; Tracy, E.T.; Vogler, C.A.; Han, X.; Song, S.-K.; Wozniak, D.F.; Klein, R.S.; et al. Bone Marrow Transplantation augments the effect of brain and spinal cord-directed Adeno-associated virus 2/5 gene therapy by altering inflammation in the murine model of Globoid-cell Leukodystrophy. J. Neurosci. 2011, 31, 9945–9957, doi:10.1523/JNEUROSCI.1802-11.2011. 21734286
[14]
Krivit, W.; Shapiro, E.G.; Peters, C.; Wagner, J.E.; Cornu, G.; Kurtzberg, J.; Wenger, D.A.; Kolodny, E.H.; Vanier, M.T.; Loes, D.J.; et al. Hematopoietic stem-cell transplantation in globoid-cell leukodystrophy. N. Engl. J. Med. 1998, 338, 1119–1126, doi:10.1056/NEJM199804163381605.
[15]
Escolar, M.L.; Poe, M.D.; Provenzale, J.M.; Richards, K.C.; Allison, J.; Wood, S.; Wenger, D.A.; Pietryga, D.; Wall, D.; Champagne, M.; et al. Transplantation of umbilical-cord blood in babies with infantile Krabbe’s disease. N. Engl. J. Med. 2005, 352, 2069–2081, doi:10.1056/NEJMoa042604. 15901860
[16]
Yeager, A.M.; Brennan, S.; Tiffany, C.; Moser, H.W.; Santos, G.W. Prolonged survival and remyelination after hematopoietic cell transplantation in the twitcher mouse. Science 1984, 225, 1052–1054, doi:10.1126/science.6382609. 6382609
[17]
Hoogerbrugge, P.M.; Poorthuis, B.J.; Wagemaker, G.; van Bekkum, D.W.; Suzuki, K. Alleviation of neurologic symptoms after bone marrow transplantation in twitcher mice. Transplant. Proc. 1989, 21, 2980–2981. 2650408
[18]
Sands, M.S.; Barker, J.E.; Vogler, C.; Levy, B.; Gwynn, B.; Galvin, N.; Sly, W.S.; Birkenmeier, E. Treatment of murine mucopolysaccharidosis type VII by syngeneic bone marrow transplantation in neonates. Lab. Invest. 1993, 68, 676–686. 8515654
